Skip to Main Content

Paper Details

A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF).
Br J Haematol
64
2013
ET, ET MF, HDACi, JAK2 V617F, LBH589, MF, PMF, PV MF, Panobinostat, Post-ET/PV MF, anaemia, fibrosis, histone deacetylase, panobinostat, patient, patients, polycythaemia vera-related myelofibrosis, post-PV, post-essential thrombocythaemia, post-polycythaemia vera/essential thrombocythaemia myelofibrosis, primary myelofibrosis, splenomegaly, thrombocytopenia

Datasets

Release 1.2